arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Genprex, Inc.

GNPX

$4.47 ▲ +0.15 (+3.47%) at close

11 Visible periods

21 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Genprex, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $4.2M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -154.0% ↗

FCF / Share $-16.42 ↘

Trailing P/E —

Price / Book 1.9x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 6, 2026.

11-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

— —

Net Income Profit after all expenses

$-16.23M

↑ +23.1% —

FCF / Share Free cash flow per share

$-16.42

↓ -283.5% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
EPS Growth YoY (%)	-225.8% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	76.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-13.9% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-4400.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—
Net Income Growth YoY (%)	23.1% Good ↑ Good Improving Year-over-year change in net income	31.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-30.0% Weak ↑ Weak Improving Year-over-year change in net income	-14.9% Weak ↑ Weak Improving Year-over-year change in net income	-15.2% Weak ↑ Weak Improving Year-over-year change in net income	-68.4% Weak ↑ Weak Improving Year-over-year change in net income	13.9% Fair ↑ Fair Improving Year-over-year change in net income	-273.3% Weak Weak Year-over-year change in net income	19.8% Good Good Year-over-year change in net income	—	—
FCF Growth YoY (%)	-283.5% Weak ↑ Weak Improving Year-over-year change in free cash flow	76.3% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-23.1% Weak Weak Year-over-year change in free cash flow	-4735.5% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
FCF / Net Income (x)	0.94x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.65x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.56x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.66x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.30x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Return on Invested Capital (%)	-154.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-1032.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-330.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-84.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-39.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-45.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-279.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-110.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-610.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-200.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-152.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-513.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-291.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-95.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-48.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-57.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-302.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-133.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-263.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-216.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-203.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1459%)	—	—	-106.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-811%)	-50.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-434%)	-58.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-487%)	—	-139.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1029%)	—	-254.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1795%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Interest Coverage (x)	—	—	—	—	—	—	—	-325.51x Weak Weak Operating income divided by interest expense Optimal: > 5x	-1752.56x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$-7.83M	$-1.60M	$-6.74M	$-20.95M	—	—	—	—	—	$-1.60M	$-234.22K

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Revenue per Share (USD)	—	$0.00	$0.00	$0.00	$0.00	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-17.40	$-5.34	$-22.56	$-19.80	$-0.44	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-16.42	$-4.28	$-18.09	$-14.70	$-0.30	—	—	—	—	—	—
Book Value per Share (USD)	$2.42	$0.15	$4.99	$18.52	$0.86	$0.72	$0.16	$0.58	$0.04	$0.14	—
Tangible Book Value per Share (USD)	$2.42	$0.15	$4.47	$17.94	$0.85	$0.70	$0.13	$0.56	$0.01	$0.12	—
Basic Weighted Avg Shares (shares)	932,730	4.01M	1.37M	1.20M	47.10M	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Working Capital (USD)	$6.18M	$-426.70K	$4.28M	$18.66M	$37.55M	$27.25M	$2.47M	$8.46M	$-637.39K	$1.35M	—
Total Equity (USD)	$7.96M	$1.62M	$7.42M	$22.27M	$41.28M	$30.92M	$3.02M	$8.88M	$428.57K	$1.62M	$393.74K

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Sales/Revenue/Turnover (USD)	—	$0.00	$0.00	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—
Depreciation Expense (USD)	$0.00	$6.69K	$15.00K	$25.57K	$22.53K	$22.78K	$13.07K	$5.88K	$3.24K	$862.00	—
Net Income, GAAP (USD)	$-16.23M	$-21.11M	$-30.86M	$-23.74M	$-20.66M	$-17.94M	$-10.65M	$-12.37M	$-3.31M	$-4.13M	—
Operating Cash Flow (USD)	$-15.31M	$-17.15M	$-24.74M	$-17.62M	$-14.28M	$-13.94M	$-6.92M	$-6.85M	$-2.17M	$-1.25M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 11 years · 40 quarters

Genprex, Inc.

Analytical Summary

11-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare GNPX with peers